Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DuoTrav in open-angle glaucoma and ocular hypertension
NCT00047528Phase 3Completed
- Sponsor
- Alcon Inc.
- Start
- Jan 2001
- Primary completion
- Nov 2003
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of travoprost, timolol in open-angle glaucoma (OAG), ocular hypertension, sponsored by Alcon Inc.. Started Jan 2001; status: completed.
02
Drugs
travoprosttimolol
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT00047528.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00047528.